Article
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Lancet (London, England) - 16 Oct 1999
Helweg-Larsen J, Benfield T L, Eugen-Olsen J, Lundgren J D, Lundgren B
Abstract excerpt
BACKGROUND: Sulpha drugs are widely used for the treatment and long-term prophylaxis of Pneumocystis carinii pneumonia (PCP) in HIV-1-infected individuals. Sulpha resistance in many microorganisms is caused by point mutations in dihydropteroate synthase (DHPS), an enzyme that is essential for folate biosynthesis. We assessed whether mutations in the DHPS gene of P. carinii were associated with exposure to sulpha...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
